H. Gerhartz
Impact in
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 12
- Hematopoietic Stem Cell Transplantation 8
- Acute Myeloid Leukemia Research 8
- Oncology 11
- Neutropenia and Cancer Infections 4
- Cancer Treatment and Pharmacology 3
- Co-authors
- W. Wilmanns (11 shared papers)D. Huhn (3 shared papers)Eckhard Thiel (2 shared papers)Markus Tiemann (1 shared paper)Henrik Griesser (1 shared paper)Günter Brittinger (1 shared paper)M. Engelhard (1 shared paper)K. Lennert (1 shared paper)
- Journals
- Journal of Molecular Medicine (5 papers)Annals of Hematology (3 papers)Leukemia Research (2 papers)Acta Haematologica (2 papers)Journal of Cancer Research and Clinical Oncology (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
H. Gerhartz
38 papers receiving 300 citations
Peers
Comparison fields: 5 of 63
- Hematology 80
- Genetics 67
- Pathology and Forensic Medicine 108
- Oncology 107
- Immunology 62
Countries citing papers authored by H. Gerhartz
This map shows the geographic impact of H. Gerhartz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Gerhartz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Gerhartz more than expected).
Fields of papers citing papers by H. Gerhartz
This network shows the impact of papers produced by H. Gerhartz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Gerhartz. The network helps show where H. Gerhartz may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Gerhartz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor. | 1997 | 90 |
| 2 | 1966 | 47 | |
| 3 | 1984 | 20 | |
| 4 | 1986 | 17 | |
| 5 | 1993 | 17 | |
| 6 | 1983 | 16 | |
| 7 | 1951 | 15 | |
| 8 | 1990 | 13 | |
| 9 | 1965 | 13 | |
| 10 | 1990 | 12 | |
| 11 | 1959 | 9 | |
| 12 | 1996 | 7 | |
| 13 | 1966 | 7 | |
| 14 | 1988 | 5 | |
| 15 | 1983 | 5 | |
| 16 | [The principles of chemotherapy with Endoxan]. | 1960 | 5 |
| 17 | THE CLINICAL RESULT OF CHEMOTHERAPY WITH ENDOXAN. | 1964 | 4 |
| 18 | 2009 | 3 | |
| 19 | 1988 | 3 | |
| 20 | 1964 | 3 |
About H. Gerhartz
H. Gerhartz is a scholar working on Hematology, Oncology, Genetics, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 42 papers that have together received 343 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (8 papers), Acute Myeloid Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Neutropenia and Cancer Infections (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and CNS Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (80 citations), Genetics (67 citations), Pathology and Forensic Medicine (108 citations), Oncology (107 citations) and Immunology (62 citations). H. Gerhartz has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include W. Wilmanns, D. Huhn, Eckhard Thiel, Markus Tiemann, Henrik Griesser, Günter Brittinger, M. Engelhard, K. Lennert, W. Siegert and P. Meusers. Their work appears in journals such as Journal of Molecular Medicine, Annals of Hematology, Leukemia Research, Acta Haematologica and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.